GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 50 filers reported holding GT BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,362 | -49.3% | 13,943 | -34.4% | 0.00% | – |
Q2 2023 | $6,631 | -43.6% | 21,254 | +61.6% | 0.00% | – |
Q4 2022 | $11,757 | -91.2% | 13,149 | -70.5% | 0.00% | – |
Q2 2022 | $133,000 | -6.3% | 44,507 | -9.6% | 0.00% | – |
Q1 2022 | $142,000 | -79.4% | 49,238 | -78.2% | 0.00% | – |
Q4 2021 | $688,000 | -42.4% | 225,924 | +27.4% | 0.00% | – |
Q3 2021 | $1,195,000 | – | 177,279 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crumly & Associates Inc. | 32,163 | $93,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 20,075 | $58,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,260 | $81,000 | 0.00% |
Sigma Planning Corp | 21,400 | $62,000 | 0.00% |
Compagnie Lombard Odier SCmA | 30,000 | $86,000 | 0.00% |
Gordian Capital Singapore Pte Ltd | 35,000 | $3,000 | 0.00% |
Welch Group, LLC | 10,000 | $29,000 | 0.00% |
Renaissance Technologies | 186,300 | $537,000 | 0.00% |
BRIGHTON JONES LLC | 11,012 | $32,000 | 0.00% |
Capital Advisors, Ltd. LLC | 24 | $0 | 0.00% |